scholarly article | Q13442814 |
P356 | DOI | 10.3390/MOLECULES21030387 |
P8608 | Fatcat ID | release_jsixp76tujdlhhjn6nbb5zazje |
P932 | PMC publication ID | 6273898 |
P698 | PubMed publication ID | 27007363 |
P2093 | author name string | Chun-Nan Yeh | |
Chung-Shan Yu | |||
Yu-Chia Chang | |||
Ying-Cheng Huang | |||
P2860 | cites work | [123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymes. | Q53121816 |
Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. | Q53541731 | ||
Cyclooxygenase-2 inhibitors in tumorigenesis (part I) | Q77470864 | ||
Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca)) | Q80458487 | ||
New insights into COX-2 biology and inhibition | Q81683819 | ||
Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis | Q24630614 | ||
A philosophy for CNS radiotracer design | Q26853140 | ||
Solution-phase parallel synthesis and screening of anti-tumor activities from fenbufen and ethacrynic acid libraries | Q33818955 | ||
18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme. | Q34027558 | ||
Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis | Q34149796 | ||
Metabolism of fluorine-containing drugs | Q34192741 | ||
Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors | Q34429206 | ||
Silver-catalyzed radical fluorination of alkylboronates in aqueous solution | Q34445232 | ||
Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors. | Q34519695 | ||
Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging | Q34632108 | ||
Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma. | Q34904867 | ||
Fluorine-18 radiochemistry, labeling strategies and synthetic routes | Q35013514 | ||
Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer | Q35545603 | ||
Investigation of brain tumors using (18)F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography | Q35907186 | ||
Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders | Q36463425 | ||
Imaging of cyclooxygenase-2 (COX-2) expression: potential use in diagnosis and drug evaluation | Q36638793 | ||
Structural and functional basis of cyclooxygenase inhibition | Q36752887 | ||
Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis | Q37465423 | ||
Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update | Q38113933 | ||
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. | Q38200729 | ||
Synthesis and structure-activity relationships of fenbufen amide analogs. | Q39624507 | ||
Synthesis, cytotoxicity, and insight into the mode of action of Re(CO)3 thymidine complexes. | Q39676844 | ||
Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation | Q40551756 | ||
cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide | Q44645672 | ||
Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma | Q44680923 | ||
Recommendations on the use of 18F-FDG PET in oncology | Q46744015 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 387 | |
P577 | publication date | 2016-03-21 | |
P1433 | published in | Molecules | Q151332 |
P1476 | title | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor--[(18)F]Fluorooctyl Fenbufen Amide--For Imaging of Brain Tumors | |
P478 | volume | 21 |
Q39369099 | Fluorine-18 labelled building blocks for PET tracer synthesis | cites work | P2860 |
Search more.